NCT03202251 is a clinical trial of It's is a cohort in Bladder Dysfunction, sponsored by The Methodist Hospital Research Institute.

Who is sponsoring NCT03202251?

NCT03202251 is sponsored by The Methodist Hospital Research Institute.

What drugs are being tested in NCT03202251?

Interventions in NCT03202251: It's is a cohort.

What condition does NCT03202251 study?

NCT03202251 studies Bladder Dysfunction, Neurogenic Bladder.

Is NCT03202251 still recruiting?

NCT03202251 is currently completed. Last updated 5 September 2021.

Last reviewed 2021-09-05 · How we verify

NCT03202251

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Deep Brain Stimulation in Patients With LUTS

Completed Last updated 5 September 2021

What this trial tests

trial testing It's is a cohort in Bladder Dysfunction in 6 participants. Completed in 25 March 2020.

Timeline

11 April 2017

Primary endpoint
25 March 2020

25 March 2020

Quick facts

Lead sponsor	The Methodist Hospital Research Institute
Status	Completed
Study type	OBSERVATIONAL
Enrollment	6
Start date	11 April 2017
Primary completion	25 March 2020
Estimated completion	25 March 2020
Sites	1 location across United States

Drugs / interventions tested

It's is a cohort

Conditions studied

Bladder Dysfunction — all drugs for Bladder Dysfunction →
Neurogenic Bladder — all drugs for Neurogenic Bladder →

Sponsor

The Methodist Hospital Research Institute

Who can join

18 and older, any sex, with Bladder Dysfunction or Neurogenic Bladder. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Deep brain stimulation (DBS) is a neurosurgical procedure using a device that improves motor symptoms of specific neurological and movement disorders such as Parkinson's disease or Essential Tremor. As part of the patient's care, the DBS is implanted when symptoms cannot be satisfactorily controlled with medications or conventional therapies. Lower urinary tract symptoms are common in patients who have underlying neurological or movement disorders and control over lower urinary tract function is poorly understood. In this study investigators are evaluating the effects of DBS on lower urinary tract function.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Deep Brain Stimulation for the Management of Refractory Neurological Disorders: A Comprehensive Review.
Rissardo JP, Vora NM, Tariq I, Mujtaba A, et al · · 2023 · cited 17× · PMID 38004040 · DOI 10.3390/medicina59111991
Does deep brain stimulation improve Parkinson's disease-related lower urinary tract symptoms and voiding dysfunction?
Tabakin AL, Tunuguntla HSGR. · · 2021 · cited 1× · PMID 34522701 · DOI 10.14440/bladder.2021.825

Verify or expand the search:

Other recruiting trials for Bladder Dysfunction

Currently open trials in the same condition.

NCT07355803 — Define Final Selection Choice Criteria for a Coloplast Catheter Ensuring Highest Patient Satisfaction Via Surveys (EVA). · NA · recruiting
NCT07019597 — NESA Neuromodulation Versus Transcutaneous Posterior Tibial Stimulation · NA · recruiting
NCT06472193 — The Utility of Shanfield Implantation Technique During Creation of Mitrofanoff Procedure in Pediatric Age Group · NA · recruiting
NCT05462561 — Vascularized Composite Bladder Allograft Transplantation · NA · recruiting
NCT05652023 — Noninvasive Ultrasound Assessment of Detrusor Dysfunction · recruiting

Other The Methodist Hospital Research Institute trials

Trials by the same sponsor.

NCT07048314 — Stem Cells for Erectile Dysfunction Post RALP · Phase 1, PHASE2 · not yet recruiting
NCT07283068 — IO Vancomycin Into the Medial Malleolus vs IV Administration in Revision TKA · NA · not yet recruiting
NCT07218484 — VoiceLove Digital Therapy for Delirium in the ICU · NA · recruiting
NCT07050771 — Comprehensive Multimodal Prehabilitation Alone or With Neoadjuvant Therapy Before Major Cancer Surgery · Phase 2 · recruiting
NCT07182279 — Neoadjuvant High Dose Rate Brachytherapy Prior to Radical Prostatectomy in Patients With Prostate Cancer · Phase 1, PHASE2 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03202251 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by The Methodist Hospital Research Institute
Last refreshed: 5 September 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03202251.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing